Evonik

Abstract In vitro compatibility assessments are a valuable tool for the early identification of potential drug–vehicle interactions. To standardize such evaluations,...

Abstract BACKGROUND: The choice of excipient is important in enhancing stability of liquid formulations containing lipid nanoparticles (LNPs) used in...

See a workshop organised by Evonik Health Care in Cambridge, MA, USA: Advanced EUDRAGIT® Workshop: Formulation Strategies and Manufacturing Approaches for...

  •         Meets the growing demand for U.S.-based contract development and manufacturing organizations (CDMOs) •         Further improves capabilities to handle...

Abstract Oral medications available for Parkinson's disease require multiple administrations, which significantly affects the plasma concentration of the drug, and...

Abstract Mucopolysaccharidosis type I (MPS-I) is a rare, multisystemic lysosomal storage disease (LSD) caused by mutations in the IDUA gene, which encodes...

Abstract Purpose: To formulate enteric-coated osmotic tablets for colon-targeted delivery of hydrocortisone. Methods: Nine core tablet batches were prepared with...

Why Evonik established a presence in Vancouver and Cambridge: to be close to cutting-edge science, innovative startups, and the next...

Abstract Purpose Simvastatin (SIM) is a widely prescribed lipid-lowering agent; however, its clinical efficacy is hindered by poor aqueous solubility...

Abstract Objectives: A customizable 3D-bioprinted core-in-shell platform was developed for time-dependent oral colon delivery of live microorganisms. The system conveyed Lacticaseibacillus paracasei as...